Latest News about TEVA
Recent news which mentions TEVA
FDA Rejects Teva - MedinCell's Schizophrenia Candidate
April 20, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Investing in Biopharma? Avoid These 2 Stocks
March 26, 2022
From Motley Fool
From Benzinga
From Benzinga
7 Drug Stocks To Consider After the Viatris Plunge
March 10, 2022
From InvestorPlace
Stocks That Hit 52-Week Lows On Friday
March 04, 2022
From Benzinga
Viatris To Pay $264M As EpiPen Antitrust Litigation Settlement: Reuters
February 28, 2022
From Benzinga
Global Cannabis Extract Market To Surpass $38B By 2030, Key Players Include Tilray, Canopy Growth, Aurora
February 17, 2022
From Benzinga
Israeli Study Reveals Promising Medical Cannabis Results, Especially For PTSD Treatment
February 16, 2022
Tickers
TEVA
From Benzinga
Teva Pharmaceutical Industries (TEVA) Q4 2021 Earnings Call Transcript
February 10, 2022
Tickers
TEVA
From Motley Fool
Why Are Teva Pharmaceutical Shares Trading Higher Today?
February 09, 2022
Tickers
TEVA
From Benzinga
The Daily Biotech Pulse: Bristol-Myers Squibb Announces $5B Accelerated Buyback, Qiagen Reaps COVID Testing Windfall, WORLDSymposium Presentations Kick In
February 09, 2022
From Benzinga
Earnings Scheduled For February 9, 2022
February 09, 2022
From Benzinga
Price To Earnings Ratio Insights For Teva Pharmaceutical
February 07, 2022
Tickers
TEVA
From Benzinga
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
From Benzinga
Are Warren Buffett's 3 Cheapest Stocks Screaming Buys?
January 31, 2022
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2022
January 27, 2022
From Benzinga
2 Best Warren Buffett Value Stocks to Buy Right Now
January 24, 2022
From Motley Fool
5 Buffett Stocks to Buy Hand Over Fist in 2022
January 24, 2022
From Motley Fool
3 Turnaround Stocks That Can Bounce Back Big Time in 2022
January 19, 2022
From Motley Fool
7 Stocks to Buy That Are Nowhere Near Being Overvalued
January 18, 2022
From InvestorPlace
Teva Suffers Loss In New York's Opioid Trial
January 03, 2022
From Benzinga
22 Stocks That Could Double Your Money in 2022
January 03, 2022
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.